title: How does weight influence tenofovir disoproxil-fumarate induced renal function decline?
authors.affiliation: Department of Internal Medicine and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.
authors.forename: Casper
authors.initials: C
authors.lastname: Rokx
authors.forename: Marchina E
authors.initials: ME
authors.lastname: Van der Ende
authors.forename: Bart J A
authors.initials: BJ
authors.lastname: Rijnders
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D001835:Body Weight; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D063065:Organophosphonates / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000139:chemically induced*
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000225:Adenine